Correction: Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer.

In the original version of [this article][1] ([1][2]), the same image was inadvertently duplicated in Fig. 5J, column #2. These errors have been corrected in the latest online HTML and PDF versions of the article. The authors regret this error. 1. 1.[↵][3]1. Li S, 2. Fong K, 3.